Together for Short Lives
Call the Helpline 0808 8088 100

Rocuronium for muscle relaxation in two children with Friedreich’s ataxia

Publication year
2004
Author(s)
Schmitt, H. J.; Wick, S.; Munster, T.
Pages
592-6
Volume
92
Number
4

Friedreich’s ataxia is a rare hereditary neurodegenerative disease caused by a defect in the gene that encodes a mitochondrial protein called frataxin. We report the use of rocuronium 0.6 mg kg(-1) in two adolescent girls with Friedreich’s ataxia undergoing propofol-sufentanil-oxygen-air anaesthesia for spinal surgery. Neuromuscular transmission was monitored using acceleromyography, and onset and recovery times were recorded. The clinical duration of rocuronium was comparable to that of children without neuromuscular disease (25% recovery T(1)=44 and 24 min for patients 1 and 2 respectively).

Research abstracts